Saakshi Medtech Board Approves Capital Hike, Preferential Issue & 34.41% Stake Acquisition in Laxmi Engineering

The Board of Directors of Saakshi Medtech & Panels , at their meeting held on May 07, 2026, approved a series of significant corporate actions, including an increase in authorised share capital, a preferential allotment of equity shares, and the acquisition of a 34.41% equity stake in Laxmi Engineering Industries Bhopal Pvt Ltd. The decisions were disclosed to the National Stock Exchange of India Limited in compliance with Regulation 30 read with Schedule III, Part A, Para A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and the SEBI master circular dated November 11, 2024.

Authorised Share Capital Increase

The board approved an increase in the authorised share capital of the company, subject to the approval of members at the ensuing Annual General Meeting. The proposed alteration will also result in a consequent change to Clause V of the Memorandum of Association of the company. The details of the existing and proposed capital structure are as follows:

Parameter: Existing Clause Proposed Clause Authorised Share Capital: Rs. 18,00,00,000/- (Rupees Eighteen Crore) Rs. 25,00,00,000/- (Twenty-Five Crore) Number of Equity Shares: 1,80,00,000 (One Crore Eighty Lakhs) 2,50,00,000 (Two Crore Fifty Lakhs) Face Value per Share: Rs. 10/- each Rs. 10/- each

Preferential Issue of Equity Shares

The board approved the issuance of 20,22,940 equity shares of face value Rs. 10 each at an issue price of Rs. 207 per equity share, which includes a premium of Rs. 197 per equity share, aggregating to Rs. 41,87,48,580. The allotment is proposed on a preferential basis to non-promoter investors in accordance with the provisions of SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended. Notably, the consideration for this issuance is other than cash — specifically, a swap of shares.

The key parameters of the preferential issue are summarised below:

Parameter: Details Type of Securities: Equity Shares Type of Issuance: Preferential Issue Total Shares to be Issued: 20,22,940 Issue Price: Rs. 207/- per equity share Face Value: Rs. 10/- per equity share Premium: Rs. 197/- per equity share Aggregate Amount: Rs. 41,87,48,580/- Category of Allottees: Non-Promoters Nature of Consideration: Other than cash (Share Swap)

Proposed Allottees — Shareholding Details

A total of 51 non-promoter allottees are proposed to receive equity shares under the preferential issue. The post-issue shareholding of notable allottees is presented below:

Allottee: Shares to be Allotted Post-Issue Shares Post-Issue % PRATHAM PRASOON 2,35,870 2,35,870 1.20% NARESH SARAAF 1,43,720 1,44,920 0.74% PRAFUL KUMAR 1,69,928 1,69,928 0.86% SNEHAL BHUPENDRA SHAH 1,69,082 1,69,082 0.86% LALIT AGRAWAL 83,696 1,16,096 0.59% SUNIL VITHALRAO CHAVAN 50,725 1,55,725 0.79% SIDDHARTHA DAGA 76,238 76,238 0.39% SATYABRATA MOHANTY 50,725 1,02,925 0.52% JASBIR SINGH CHOUHAN 53,261 55,061 0.28% SAURABH MEHTA 53,261 53,261 0.27% Girish Paman Vanvari 50,725 50,725 0.26% HASTI MEET MEHTA 50,725 50,725 0.26% HIREN RAJENDRA MEHTA 50,725 50,725 0.26% HITEN POPATLAL SHAH 50,725 62,725 0.32% KIRAN I KARNAWAT 50,725 50,725 0.26% RUPA KISHOR SHAH 50,725 50,725 0.26% Total (All Allottees): 20,22,940 — —

Acquisition of 34.41% Stake in Laxmi Engineering Industries Bhopal Pvt Ltd

In addition to the capital restructuring actions, the board also approved the acquisition of 34.41% equity shareholding in Laxmi Engineering Industries Bhopal Pvt Ltd ("Target Company") for a total consideration of INR 41.87 crore. The acquisition will be completed through a share swap, wherein Saakshi Medtech & Panels will issue 20,22,940 equity shares against the acquisition of 23,92,850 equity shares of the Target Company. The acquisition will be completed upon the completion of the preferential allotment to the shareholders of the Target Company. No governmental or regulatory approvals are required for this acquisition.

The key details of the acquisition are summarised below:

Parameter: Details Target Company: Laxmi Engineering Industries Bhopal Pvt Ltd Stake Acquired: 34.41% Total Consideration: INR 41.87 Crore Nature of Consideration: Swap of Shares Shares Issued by Acquirer: 20,22,940 equity shares Shares Acquired in Target: 23,92,850 equity shares Completion Trigger: On completion of preferential allotment Regulatory Approvals Required: None

About Laxmi Engineering Industries Bhopal Pvt Ltd

Laxmi Engineering Industries Bhopal Pvt Ltd (LEI) is an India-based engineering company engaged in the design, engineering, and manufacturing of customised heat transfer equipment and allied heavy engineering solutions. Its product portfolio includes shell and tube heat exchangers, air-cooled heat exchangers, surface condensers, feed water heaters, pressure vessels, finned tube heat exchangers, deaerators, and other fabricated assemblies used across sectors such as power generation (thermal, hydro, nuclear, and solar), oil & gas, chemicals, fertilisers, cement, sugar, and other industrial process plants. LEI traces its origins to 1987, when it was established as a partnership firm, and was subsequently converted into a private limited company in July 2007. The company is compliant with quality standards such as ISO 9001:2015 and manufactures in accordance with applicable industry codes including ASME guidelines and Indian Boiler Regulations. LEI has established relationships with reputed customers including BHEL, NTPC, GAIL, IOCL, L&T, and Mitsubishi, among others, and has also executed export orders across regions including the Middle East, South Asia, and Eurasia. Its manufacturing facilities are located in Bhopal, Madhya Pradesh.

The last three years' turnover of the Target Company is presented below:

Year: Turnover (Rs. in crore) 2025-26 (Provisional): 20.29 2024-25: 17.80 2023-24: 12.13

The proposed acquisition is described as a strategic investment aimed at expanding Saakshi Medtech & Panels' presence within the broader engineering and industrial ecosystem. While the Target Company's operations are not identical to the company's current business of electrical panels and related systems, both operate within the wider domain of industrial engineering and infrastructure solutions, with overlapping customer segments and project environments.

Extraordinary General Meeting Scheduled

To seek shareholder approval for the aforementioned resolutions, the board approved convening an Extraordinary General Meeting on June 02, 2026, at 03:00 p.m., to be held through Video Conferencing / Other Audio Visual Means (VC/OAVM). The board also approved the draft EGM notice, explanatory statement, calendar of events, and other related documents. The formal notice of the EGM will be shared with shareholders in due course.

Additionally, the board approved the appointment of M/s. Jay Pandya & Associates, Practicing Company Secretary (Membership No. A63213, Certificate of Practice No. 24319), as Scrutinizer for conducting e-voting and providing the requisite report for the resolutions to be passed at the EGM. The disclosures required under Regulation 30 of the Listing Regulations, as detailed in Annexure A and Annexure B, have been submitted to the stock exchange and are also hosted on the company's website.

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.

As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.

We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.

This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.

The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.

We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.

This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.

By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.

We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.